The net cash of Yew Bio-Pharm Group with headquarters in the United States amounted to 17.3 million U.S. dollars in 2020. The reported fiscal year ends on December 31.

Compared to the earliest depicted value from 2016 this is a total increase by approximately 16.7 million U.S. dollars. The trend from 2016 to 2020 shows, however, that this increase did not happen continuously.